advertisement

Cancer

26 August 2010

New drug shrinks melanomas

An experimental therapy that targets the protein that feeds certain types of advanced melanomas has successfully shrunk tumours in up to 80% of test patients.

An experimental therapy that targets the protein that feeds certain types of advanced melanomas has successfully shrunk tumours in up to 80% of test patients, a study said.

"Metastatic melanoma has a devastating prognosis and is one of the top causes of cancer death in young patients," said Keith Flaherty of the Massachusetts General Hospital Cancer Centre and a lead author.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit cansa.org.za.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules